Loss of the Histone Methyltransferase EZH2 induces Resistance to Multiple Drugs in Acute Myeloid Leukemia

In acute myeloid leukemia (AML), therapy resistance occurs frequently and leads to high mortality of the disease. However, the mechanisms that render leukemic cells drug resistant remain largely undefined. Here, we identified loss of the histone methyltransferase EZH2 and subsequent reduction of his...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nat Med
Autores principales: Göllner, Stefanie, Oellerich, Thomas, Agrawal-Singh, Shuchi, Schenk, Tino, Klein, Hans-Ulrich, Rohde, Christian, Pabst, Caroline, Sauer, Tim, Lerdrup, Mads, Tavor, Sigal, Stölzel, Friedrich, Herold, Sylvia, Ehninger, Gerhard, Köhler, Gabriele, Pan, Kuan-Ting, Urlaub, Henning, Serve, Hubert, Dugas, Martin, Spiekermann, Karsten, Vick, Binje, Jeremias, Irmela, Berdel, Wolfgang E., Hansen, Klaus, Zelent, Arthur, Wickenhauser, Claudia, Müller, Lutz P., Thiede, Christian, Müller-Tidow, Carsten
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548550/
https://ncbi.nlm.nih.gov/pubmed/27941792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4247
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares